Nvidia Chips Linked to China's AI Push, Report Claims
A Bloomberg report says Moonshot AI accessed Nvidia H200 chips via Alibaba, raising fresh questions about China's self-sufficient AI narrative.
A new Bloomberg report is challenging the notion that China built its most advanced artificial intelligence models entirely on homegrown technology, finding that Nvidia chips may have played a significant role in the process. Specifically, the report alleges that Alibaba held an agreement allowing Moonshot AI, a prominent Chinese AI startup, to access Nvidia H200 processors — some of the most powerful chips available for AI workloads.
The revelation carries major geopolitical weight. U.S. export controls have sought to block Chinese companies from obtaining advanced Nvidia chips, making any evidence of workarounds a flashpoint in the ongoing technology rivalry between Washington and Beijing. If confirmed, the arrangement would suggest that restrictions designed to limit China's AI capabilities may be facing circumvention through indirect access agreements.
Read more New York Sues Kalshi Over Alleged Illegal Gambling Operation →
Alibaba moved quickly to dispute the Bloomberg findings, pushing back against the characterization of its relationship with Moonshot AI. The Chinese tech giant did not confirm the existence of the alleged chip-sharing arrangement, adding a layer of uncertainty to what is already a murky and politically sensitive situation. Moonshot AI has not publicly addressed the claims in detail.
The episode underscores a persistent challenge for U.S. policymakers: even as the Commerce Department tightens restrictions on semiconductor exports, enforcement gaps and third-party arrangements can blur the line between compliance and evasion. Analysts have long warned that determined actors can find indirect pathways to restricted hardware, particularly through cloud computing arrangements that may not trigger the same export control scrutiny as direct chip sales.
The story adds fresh complexity to the global AI race at a moment when Chinese labs have been showcasing competitive models, prompting debate over whether U.S. export restrictions are achieving their intended strategic effect. Continue reading at MarketWatch.com
